Leiomyoma Follow-up

  • Author: Kyle L Horner; Chief Editor: William D James, MD   more...
 
Updated: Jan 12, 2012
 

Complications

  • Cosmetic disfigurement can occur in association with the presence of multiple piloleiomyomas.
  • Pain is present in most cases.
Next

Prognosis

  • The prognosis for a solitary lesion is excellent, especially if it is surgically excised.
  • Multiple piloleiomyomas gradually increase in size and number.
Previous
 
Contributor Information and Disclosures
Author

Kyle L Horner  MD, MS, Staff Physician, Silver Falls Dermatology, Corvallis, OR

Kyle L Horner is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Gregory J Raugi, MD, PhD  Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle School of Medicine; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle

Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Marion C Miethke, MD  Clinical Assistant Professor, Department of Internal Medicine, Section of Dermatology, University of Washington

Marion C Miethke, MD is a member of the following medical societies: Phi Beta Kappa

Disclosure: Nothing to disclose.

Specialty Editor Board

Carrie L Kovarik, MD  Assistant Professor of Dermatology, Dermatopathology, and Infectious Diseases, University of Pennsylvania School of Medicine

Carrie L Kovarik, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

Michael J Wells, MD  Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Rosalie Elenitsas, MD  Herman Beerman Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System

Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology

Disclosure: Lippincott Williams Wilkins Royalty Textbook editor; DLA Piper Consulting fee Consulting

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD  Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

References

  1. Virchow R. Ueber Makroglossie und pathologische Neubildung quergestreifter Muskelfasern. Virchows Arch (Pathol Anat). 1854;7:126-38.

  2. Kloepfer HW, Krafchuk J, Derbes V. Hereditary multiple leiomyoma of the skin. Am J Hum Genet. Mar 1958;10(1):48-52. [Medline].

  3. Utikal J, Haus G, Poenitz N, Koenen W, Back W, Dippel E. Cutaneous leiomyosarcoma with myxoid alteration arising in a setting of multiple cutaneous smooth muscle neoplasms. J Cutan Pathol. Sep 2006;33 Suppl 2:20-3. [Medline].

  4. Brooks JK, Nikitakis NG, Goodman NJ, Levy BA. Clinicopathologic characterization of oral angioleiomyomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Aug 2002;94(2):221-7. [Medline].

  5. Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol. Sep 2010;116(3):641-52. [Medline].

  6. Holst VA, Junkins-Hopkins JM, Elenitsas R. Cutaneous smooth muscle neoplasms: clinical features, histologic findings, and treatment options. J Am Acad Dermatol. Apr 2002;46(4):477-90; quiz, 491-4. [Medline].

  7. Ramesh P, Annapureddy SR, Khan F, Sutaria PD. Angioleiomyoma: a clinical, pathological and radiological review. Int J Clin Pract. Jun 2004;58(6):587-91. [Medline].

  8. Gokdemir G, Sakiz D, Koslu A. Multiple cutaneous leiomyomas of the nipple. J Eur Acad Dermatol Venereol. Apr 2006;20(4):468-9. [Medline].

  9. Nagata S, Nishimura H, Uchida M, Hayabuchi N, Zenmyou M, Fukahori S. Giant angioleiomyoma in extremity: report of two cases. Magn Reson Med Sci. Jul 2006;5(2):113-8. [Medline].

  10. Yagi K, Hamada Y, Yasui N. A leiomyoma arising from the deep palmar arterial arch. J Hand Surg [Br]. Dec 2006;31(6):680-2. [Medline].

  11. Alam NA, Bevan S, Churchman M, Barclay E, Barker K, Jaeger EE, et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet. May 2001;68(5):1264-9. [Medline].

  12. Alam NA, Olpin S, Rowan A, Kelsell D, Leigh IM, Tomlinson IP, et al. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn. Oct 2005;7(4):437-43. [Medline].

  13. Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. Jul 2005;153(1):11-7. [Medline].

  14. Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. Jan 2006;43(1):18-27. [Medline].

  15. Badeloe S, van Geel M, van Steensel MA, Bastida J, Ferrando J, Steijlen PM, et al. Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol. Sep 2006;15(9):735-41. [Medline].

  16. Horton E, Dobin SM, Debiec-Rychter M, Donner LR. A clonal translocation (7;8)(p13;q11.2) in a leiomyoma of the vulva. Cancer Genet Cytogenet. Oct 1 2006;170(1):58-60. [Medline].

  17. Naguib NN, Nour-Eldin NE, Serag Eldin F, Mazloum YZ, Agameya AF, Abou Seif S, et al. Uterine Artery Embolization for Uterine Leiomyoma: Role of Uterine Artery Doppler in the Pre-Interventional, Interventional and Post-interventional Patient Workup. Ultrasound Obstet Gynecol. Dec 16 2011;[Medline].

  18. Woertler K. Soft tissue masses in the foot and ankle: characteristics on MR Imaging. Semin Musculoskelet Radiol. Sep 2005;9(3):227-42. [Medline].

  19. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Toi M. Lack of CD34 positive stromal cells within angiomyomas (vascular leiomyomas). J Clin Pathol. May 2002;55(5):395-6. [Medline].

  20. Batchelor RJ, Lyon CC, Highet AS. Successful treatment of pain in two patients with cutaneous leiomyomata with the oral alpha-1 adrenoceptor antagonist, doxazosin. Br J Dermatol. Apr 2004;150(4):775-6. [Medline].

  21. Alam M, Rabinowitz AD, Engler DE. Gabapentin treatment of multiple piloleiomyoma-related pain. J Am Acad Dermatol. Feb 2002;46(2 Suppl Case Reports):S27-9. [Medline].

  22. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol. Jun 2003;42(6):491-5. [Medline].

  23. Sifaki MK, Krueger-Krasagakis S, Koutsopoulos A, Evangelou GI, Tosca AD. Botulinum toxin type A--treatment of a patient with multiple cutaneous piloleiomyomas. Dermatology. 2009;218(1):44-7. [Medline].

  24. Onder M, Adisen E. A new indication of botulinum toxin: leiomyoma-related pain. J Am Acad Dermatol. Feb 2009;60(2):325-8. [Medline].

  25. Gravvanis A, Kakagia D, Papadopoulos S, Tsoutsos D. Dermal skin template for the management of multiple cutaneous leiomyomas. J Cutan Med Surg. Mar-Apr 2009;13(2):102-5. [Medline].

  26. Abraham Z, Cohen A, Haim S. Muscle relaxing agent in cutaneous leiomyoma. Dermatologica. 1983;166(5):255-6. [Medline].

  27. Archer CB, Greaves MW. Assessment of treatment for painful cutaneous leiomyomas [letter]. J Am Acad Dermatol. Jul 1987;17(1):141-2. [Medline].

  28. Archer CB, Whittaker S, Greaves MW. Pharmacological modulation of cold-induced pain in cutaneous leiomyomata. Br J Dermatol. Feb 1988;118(2):255-60. [Medline].

  29. Chuang GS, Martinez-Mir A, Geyer A, Engler DE, Glaser B, Cserhalmi-Friedman PB, et al. Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata. J Am Acad Dermatol. Mar 2005;52(3 Pt 1):410-6. [Medline].

  30. Fernandez-Pugnaire MA, Delgado-Florencio V. Familial multiple cutaneous leiomyomas. Dermatology. 1995;191(4):295-8. [Medline].

  31. Fitzpatrick JE, Mellette JR Jr, Hwang RJ, Golitz LE, Zaim MT, Clemons D. Cutaneous angiolipoleiomyoma. J Am Acad Dermatol. Dec 1990;23(6 Pt 1):1093-8. [Medline].

  32. García Muret MP, Pujol RM, Alomar A, Calaf J, de Moragas JM. Familial leiomyomatosis cutis et uteri (Reed's syndrome). Arch Dermatol Res. 1988;280 Suppl:S29-32. [Medline].

  33. Geddy PM, Gray S, Reid WA. Mast cell density and PGP 9.5-immunostained nerves in angioleiomyoma: their relationship to painful symptoms. Histopathology. Apr 1993;22(4):.5-immunostained nerves in angioleiomyoma: their relationship to painful sympto. [Medline].

  34. Laporte M, Achten G, Gheeraert P, Lowy M, Vokaer A. [Multiple leiomyoma treated with nifedipine: association with an astrocytoma]. Dermatologica. 1985;171(6):486-90. [Medline].

  35. Newman PL, Fletcher CD. Smooth muscle tumours of the external genitalia: clinicopathological analysis of a series [published erratum appears in Histopathology 1991 Aug;19(2):198]. Histopathology. Jun 1991;18(6):523-9. [Medline].

  36. Raj S, Calonje E, Kraus M, Kavanagh G, Newman PL, Fletcher CD. Cutaneous pilar leiomyoma: clinicopathologic analysis of 53 lesions in 45 patients. Am J Dermatopathol. Feb 1997;19(1):2-9. [Medline].

  37. Spencer JM, Amonette RA. Tumors with smooth muscle differentiation. Dermatol Surg. Sep 1996;22(9):761-8. [Medline].

  38. Thompson JA Jr. Therapy for painful cutaneous leiomyomas. J Am Acad Dermatol. Nov 1985;13(5 Pt 2):865-7. [Medline].

  39. Vellanki LS, Camisa C, Steck WD. Familial leiomyomata. Cutis. Jul 1996;58(1):80-2. [Medline].

  40. Venencie PY, Bigel P, de la Charrière O, Lemonnier V, Thébaut-Gerbaud D, Saurat JH. [Multiple cutaneous leiomyomatosis. Treatment with phenoxybenzamine]. Ann Dermatol Venereol. 1982;109(9):819-20. [Medline].

  41. Venencie PY, Puissant A, Boffa GA, Sohier J, Duperrat B. Multiple cutaneous leiomyomata and erythrocytosis with demonstration of erythropoietic activity in the cutaneous leiomyomata. Br J Dermatol. Oct 1982;107(4):483-6. [Medline].

 
Previous
Next
 
These multiple hyperpigmented nodules are piloleiomyomas on an upper extremity.
Upon closer inspection, one can appreciate that these piloleiomyomas are superficial dermal nodules.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.